Indices of iron status in continuous ambulatory peritoneal dialysis patients

American Journal of Kidney Diseases

Volumn 34, Issue 1, 1999, Pages 29-35

  Domrongkitchaiporn, S ^a   Jirakranont, B ^a   Atamasrikul, K ^a   Ungkanont, A ^a   Bunyaratvej, A ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bone marrow; Continuous ambulatory peritoneal dialysis; Ferritin; Iron deficiency; Reticulocyte hemoglobin; Transferrin

Indexed keywords

FERRITIN; FERROUS SULFATE; HEMOGLOBIN; IRON; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; IRON THERAPY; MALE; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT; TREATMENT OUTCOME;

EID: 0033034370     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70104-6     Document Type: Article

References (31)

1. IC MacDougall Poor response to erythropoietin: Practical guideline on investigation and management Nephrol Dial Transplant 10 1995 607 614
2. JW Eschbach JW Adamson Recombinant human erythropoietin: Implications for nephrology Am J Kidney Dis 11 1989 203 209
3. G Sunder-Plassman WH Hörl Importance of iron supply for erythropoietin therapy Nephrol Dial Transplant 10 1995 2070 2076
4. IC MacDougall I Cavill B Hulme B Bain E McGreger P McKay E Sanders GA Coles JD Williams Detection of iron deficiency during erythropoietin treatment: A new approach Br Med J 304 1992 225 226
5. RM Schaefer L Schaefer The hypochromic red cell: A new parameter for monitoring of iron supplementation during rhEPO therapy J Perinat Med 23 1995 83 88
6. BJ Ferguson BS Skikne KM Simpson RD Baynes JD Cook Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia J Lab Clin Med 119 1992 358 390
7. AM Konijin C Hershko Ferritin synthesis in inflammation: Pathogenesis of iron release Br J Haematol 37 1977 7 16
8. G Birgegard R Hällgren A Killander A Stromberg P Venge L Wide Serum ferritin during infection. A longitudinal study Scand J Haematol 21 1978 333 340
9. RD Baynes Assessment of iron status Clin Biochem 29 1996 209 215
10. JT Hazard JW Drysdale Ferritinaemia in cancer [letter] Nature 265 1977 755 756
11. JW Eschbach MR Kelly NR Haley RI Abels JW Adamson Treatment of the anemia of progressive renal failure with recombinant human erythropoietin N Engl J Med 321 1989 158 163
12. RH Barth A Aboul-Magd P Goldwasser Response to iron dextran therapy is not precluded by high serum ferritin J Am Soc Nephrol 6 1995 519A (abstr)
13. DC Tarng TW Chen TP Huang Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintanance hemodialysis patients Am J Nephrol 15 1995 230 237
14. I Cavill Disorder of iron metabolism. Diagnostic methods Clin Haematol 11 1982 259 273
15. K Kalantar-Zadeh B Höffken H Wunsch H Fink M Kleiner FC Luft Diagnosis of iron deficiency anemia in renal failure patients during the post erythropoietin era Am J Kidney Dis 26 1995 292 299
16. S Fishbane EA Kowalski LJ Imbriano JK Maesaka The evaluation of iron status in hemodialysis patients J Am Soc Nephrol 7 1996 2654 2657
17. RI Lynn R Dressler SD Levine Low initial transferrin saturation (Tsat) does not predict a poor response to erythropoietin (EPO) in hemodialysis (HD), and may not increase with intravenous iron dextran (IVFe) J Am Soc Nephrol 1 1990 402A (abstr)
18. S Fishbane C Galgano RC Langley W Canfield KJ Maesaka Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients Kidney Int 52 1997 217 222
19. R Raja E Bloom R Johnson M Goldstein Improve response to erythropoietin in peritoneal dialysis patients as compare to hemodialysis patients: Role of iron deficiency Adv Perit Dial 10 1994 135 138
20. RM Hakim Clinical implication of hemodialysis biocompatibility Kidney Int 44 1993 484 494
21. S Shaldon G Lonnemann KM Koch Cytokine release in biocompatibility Contrib Nephrol 79 1989 227 361
22. JW Escbach The anemia of chronic renal failure: Pathophysiology and the effects of recombinant human erythropoietin Kidney Int 35 1989 134 148
23. H Suh NK Wadhwa Iron dextran treatment in peritoneal dialysis patients on erythropoietin Adv Perit Dial 8 1992 464 466
24. N Ahsan JA Groff MM Waybill Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant erythropoietin Adv Perit Dial 12 1996 161 166
25. AR Nissenson Achieving target hematocrit in dialysis patients: New concepts in iron management Am J Kidney Dis 30 1997 907 911
26. N Ahsan Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: A single center comparative study J Am Soc Nephrol 9 1998 664 668
27. NKF-DOQI: Clinical practice guidelines for the treatment of anemia: III Iron support Am J Kidney Dis 30 suppl 3 1997 S202 S212
28. A Jacobs J Worwood Ferritin in serum N Engl J Med 292 1975 951 982
29. S Fishbane JK Maesaka Iron management in end-stage renal disease Am J Kidney Dis 29 1997 319 333
30. M Ali AO Fayemi Rigolosi J Frascino T Marsden D Malcolm Hemosiderosis in hemodialysis patients: An autopsy study of 50 cases JAMA 25 1980 343 345
31. N Mittman R Sreedhara R Mushnick J Chatlopadhyay D Zelmanovic M Vaseghi M Avram Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO Am J Kidney Dis 30 1997 912 922